Non-Antibody Products — page 1 of 31,998
Non-Antibody Products
Page 1 of 31,998
| Name | Description | Size | Catalog # | Supplier | |
|---|---|---|---|---|---|
| A 205804 | Purity ≥98%. MW: 300.39 | 100 mg, 500 mg | MBS132392 |
 MYBIOSOURCE INC. |
More Info |
| A 66 | Purity ≥98%. MW: 393.52 | 100 mg, 500 mg | MBS132169 |
MYBIOSOURCE INC. |
More Info |
| A 740003 | Purity ≥98%. MW: 474.565 | 100 mg, 500 mg | MBS132187 |
MYBIOSOURCE INC. |
More Info |
| A 740003 | Purity >98%. A 740003 is a novel competitive antagonist of P2X7 receptors… | 10 mg, 25 mg, 50 mg | MBS384091 |
MYBIOSOURCE INC. |
More Info |
| A 769662 | Purity ≥98%. MW: 360.39 | 100 mg, 500 mg | MBS130892 |
MYBIOSOURCE INC. |
More Info |
| A 769662 | Purity 97%+. MW: 360.39 | 5 mg, 1ml/10mM (in DMSO), 10 mg | MBS576261 |
MYBIOSOURCE INC. |
More Info |
| A 803467 | Purity >98%. A 803467 is a selective blocker of NaV1.8 channels (IC50 valu… | 10 mg, 1 mL (in DMSO), 25 mg | MBS384093 |
MYBIOSOURCE INC. |
More Info |
| A 83-01 | Purity ≥98% by HPLC. Background: A selective inhibitor of TGF-beta type… | 1 mg | MBS842636 |
MYBIOSOURCE INC. |
More Info |
| A 83-01 | Purity ≥98%. MW: 421.52 | 100 mg, 500 mg | MBS132328 |
MYBIOSOURCE INC. |
More Info |
| A 83-01 | Purity >98%. A83-01 is a TGF-β kinase / activin receptor like kinase… | 5 mg, 10 mg, 25 mg | MBS384095 |
MYBIOSOURCE INC. |
More Info |
| A 922500 | MW: 428.48 | 5 mg | MBS8506458 |
MYBIOSOURCE INC. |
More Info |
| A 922500 | Purity ≥98%. MW: 428.488 | 100 mg, 500 mg | MBS130245 |
MYBIOSOURCE INC. |
More Info |
| A 967079 | Purity >98%. A 967079 is a selective TRPA1 channel blocker (IC50 values ar… | 10 mg, 25 mg, 50 mg | MBS384097 |
MYBIOSOURCE INC. |
More Info |
| A-1155463 | Purity >98%. A-1155463 is a highly potent and selective BCL-XL inhibitor,… | 5 mg, 10 mg, 50 mg | MBS384082 |
MYBIOSOURCE INC. |
More Info |
| A-1210477 | Purity ≥98%. MW: 886.51 | 100 mg, 500 mg | MBS131280 |
MYBIOSOURCE INC. |
More Info |
| A-1210477 | Purity ≥99%. MW: 850.04 | 2 mg, 5 mg, 10 mg | MBS575263 |
MYBIOSOURCE INC. |
More Info |
| A-1210477 | Purity >98%. A-1210477 is a potent and selective MCL-1 inhibitor. A-121047… | 5 mg, 10 mg, 25 mg | MBS384084 |
MYBIOSOURCE INC. |
More Info |
| A-1331852 | Purity ≥98%. MW: 658.82 | 100 mg, 500 mg | MBS131656 |
MYBIOSOURCE INC. |
More Info |
| A-196 | Purity ≥99%. A-196 is a potent and selective inhibitor of SUV420 h1 and… | 2 mg, 1ml/10mM (in DMSO), 5 mg | MBS5750478 |
MYBIOSOURCE INC. |
More Info |
| A-205804 | Purity 97%+. MW: 300.41 | 5 mg, 10 mg, 1ml/10mM (in DMSO) | MBS576130 |
MYBIOSOURCE INC. |
More Info |
| A23187 | Purity >98% by TLC. Background: A calcium ionophore. Causes rapid influx o… | 10 mg | MBS843148 |
MYBIOSOURCE INC. |
More Info |
| A-366 | Purity ≥98% by HPLC. Background: A-366 is a potent and selective G9a /… | 1 mg, 5 mg | MBS842453 |
MYBIOSOURCE INC. |
More Info |
| A-366 | Purity ≥98%. MW: 329.444 | 100 mg, 500 mg | MBS131198 |
MYBIOSOURCE INC. |
More Info |
| A-366 | Purity >98%. A-366 is a potent and selective G9a / GLP histone lysine meth… | 10 mg, 25 mg, 50 mg | MBS384085 |
MYBIOSOURCE INC. |
More Info |
| A427 | A427 cells are derived from human lung epithelial carcinoma taken from a 5… | 0.1 mg, 0.2 mg, 0.5 mg | MBS201043 |
MYBIOSOURCE INC. |
More Info |
| A431 | A431 cells were established from an epidermoid carcinoma in the skin / epi… | 0.1 mg, 0.2 mg, 0.5 mg | MBS201022 |
MYBIOSOURCE INC. |
More Info |
| A-443654 | Purity >98%. A-443654, a specific Akt inhibitor with Ki value of 160 pM, i… | 2 mg, 5 mg, 10 mg | MBS384086 |
MYBIOSOURCE INC. |
More Info |
| A-484954 | Purity >98%. A-484954 is a potent, selective inhibitor of eukaryotic longa… | 10 mg, 25 mg, 50 mg | MBS384087 |
MYBIOSOURCE INC. |
More Info |
| A549 | A549 cells are adenocarcinomic human alveolar basal epithelial cells. The… | 0.1 mg, 0.2 mg, 0.5 mg | MBS201023 |
MYBIOSOURCE INC. |
More Info |
| A66 | MW: 393.53 | 10 mg | MBS8506193 |
MYBIOSOURCE INC. |
More Info |
| A66 | Purity >98%. The S-enantiomer of A66 is a potent inhibitor of the p110alph… | 5 mg, 1 mL (in DMSO), 10 mg | MBS384089 |
MYBIOSOURCE INC. |
More Info |
| A66 | Purity 97%+. MW: 393.53 | 2 mg, 5 mg, 1ml/10mM (in DMSO) | MBS575616 |
MYBIOSOURCE INC. |
More Info |
| A-674563 | MW: 358.44 | 2 mg | MBS8506244 |
MYBIOSOURCE INC. |
More Info |
| A-674563 | Purity ≥98%. A-674563 is an Akt1 inhibitor with Ki of 11 nM, modest pot… | 1 mg, 2 mg, 5 mg | MBS578707 |
MYBIOSOURCE INC. |
More Info |
| A-674563 | Purity ≥98%. MW: 358.445 | 100 mg, 500 mg | MBS131746 |
MYBIOSOURCE INC. |
More Info |
| A-674563 | Purity >98%. A-674563 is a B / Akt inhibitor with an IC50 of 14 nM and als… | 5 mg, 1 mL (in DMSO), 10 mg | MBS384090 |
MYBIOSOURCE INC. |
More Info |
| A-769662 | Purity ≥98% by HPLC. Background: Cell-permeable. A potent AMPK activato… | 5 mg | MBS842018 |
MYBIOSOURCE INC. |
More Info |
| A-769662 | Purity >98%. A-769662 is a new activator of AMP-activated protein kinase (… | 5 mg, 10 mg, 1 mL (in DMSO) | MBS384092 |
MYBIOSOURCE INC. |
More Info |
| A77 1726 | Purity ≥98% by HPLC. Background: Physiologically active metabolite of t… | 5 mg, 25 mg | MBS842963 |
MYBIOSOURCE INC. |
More Info |
| A77-01 | Purity ≥98%. MW: 286.33 | 2 mg, 5 mg, 1ml/10mM (in DMSO) | MBS577536 |
MYBIOSOURCE INC. |
More Info |
| A77-01 | Purity ≥98%. MW: 286.338 | 100 mg, 500 mg | MBS130865 |
MYBIOSOURCE INC. |
More Info |
| A-803467 | Purity ≥98% (TLC). MW: 357.8 | 10 mg, 50 mg | MBS565381 |
MYBIOSOURCE INC. |
More Info |
| A-803467 | Purity ≥98% by TLC. Background: A-803467 is a potent, selective inhibit… | 5 mg, 25 mg | MBS842200 |
MYBIOSOURCE INC. |
More Info |
| A-803467 | Purity ≥98%. MW: 357.79 | 100 mg, 500 mg | MBS132100 |
MYBIOSOURCE INC. |
More Info |
| A-803467 | Purity ≥98%. MW: 357.79 | 1ml/10mM (in DMSO), 10 mg, 25 mg | MBS575739 |
MYBIOSOURCE INC. |
More Info |
| A-804598 | Purity >98%. A-804598 is a P2X7 selective, competitive antagonist with the… | 5 mg, 10 mg, 25 mg | MBS384094 |
MYBIOSOURCE INC. |
More Info |
| A83-01 | Purity >98% (TLC); NMR (Conforms). ALK inhibitor. Selective glycogen synth… | 5 mg, 25 mg | MBS515040 |
MYBIOSOURCE INC. |
More Info |
| A-83-01 | Purity 97%+. MW: 421.52 | 2 mg, 5 mg, 10 mg | MBS575483 |
MYBIOSOURCE INC. |
More Info |
| A-966492 | A-966492 is a highly potent and efficacious poly(ADP-ribose) polymerase (P… | 10 mg | MBS8506196 |
MYBIOSOURCE INC. |
More Info |
| A-966492 | Purity ≥98%. A-966492 is a novel and potent inhibitor of PARP1 and PARP… | 2 mg, 5 mg, 1ml/10mM (in DMSO) | MBS578914 |
MYBIOSOURCE INC. |
More Info |
| A-966492 | Purity ≥98%. MW: 324.359 | 100 mg, 500 mg | MBS132689 |
MYBIOSOURCE INC. |
More Info |
| A-966492 | Purity >98%. A-966492 displayed high potency against the poly(ADP-ribose)… | 5 mg, 1 mL (in DMSO), 10 mg | MBS384096 |
MYBIOSOURCE INC. |
More Info |
| A1120 | n/a | n/a | A3111 |
 MILLIPORE-SIGMA |
More Info |
| A 83-01 | An inhibitor of ALK5, ALK4, and ALK7 (IC50s = 12, 45, and 7.5 nM, respecti… | 1 mg | 9001799-1 |
 CAYMAN CHEMICAL COMPANY |
More Info |
| A 83-01 | An inhibitor of ALK5, ALK4, and ALK7 (IC50s = 12, 45, and 7.5 nM, respecti… | 10 mg | 9001799-10 |
CAYMAN CHEMICAL COMPANY |
More Info |
| A 83-01 | An inhibitor of ALK5, ALK4, and ALK7 (IC50s = 12, 45, and 7.5 nM, respecti… | 25 mg | 9001799-25 |
CAYMAN CHEMICAL COMPANY |
More Info |
| A 83-01 | An inhibitor of ALK5, ALK4, and ALK7 (IC50s = 12, 45, and 7.5 nM, respecti… | 5 mg | 9001799-5 |
CAYMAN CHEMICAL COMPANY |
More Info |
| A01 | A Smurf1 inhibitor (Kd = 3.67 nM); inhibits Smurf1-mediated ubiquitination… | 10 mg | 26137-10 |
CAYMAN CHEMICAL COMPANY |
More Info |
| A01 | A Smurf1 inhibitor (Kd = 3.67 nM); inhibits Smurf1-mediated ubiquitination… | 25 mg | 26137-25 |
CAYMAN CHEMICAL COMPANY |
More Info |
| A01 | A Smurf1 inhibitor (Kd = 3.67 nM); inhibits Smurf1-mediated ubiquitination… | 5 mg | 26137-5 |
CAYMAN CHEMICAL COMPANY |
More Info |
| A01 | A Smurf1 inhibitor (Kd = 3.67 nM); inhibits Smurf1-mediated ubiquitination… | 50 mg | 26137-50 |
CAYMAN CHEMICAL COMPANY |
More Info |
| A-1070722 | A GSK3β inhibitor (IC50 = <100 nM) | 1 mg | 29783-1 |
CAYMAN CHEMICAL COMPANY |
More Info |
| A-1070722 | A GSK3β inhibitor (IC50 = <100 nM) | 10 mg | 29783-10 |
CAYMAN CHEMICAL COMPANY |
More Info |
| A-1070722 | A GSK3β inhibitor (IC50 = <100 nM) | 25 mg | 29783-25 |
CAYMAN CHEMICAL COMPANY |
More Info |
| A-1070722 | A GSK3β inhibitor (IC50 = <100 nM) | 5 mg | 29783-5 |
CAYMAN CHEMICAL COMPANY |
More Info |
| A-1120 | An RBP4 antagonist (Ki = 8.3 nM for disruption of RBP4 binding to transthy… | 10 mg | 30921-10 |
CAYMAN CHEMICAL COMPANY |
More Info |
| A-1120 | An RBP4 antagonist (Ki = 8.3 nM for disruption of RBP4 binding to transthy… | 5 mg | 30921-5 |
CAYMAN CHEMICAL COMPANY |
More Info |
| A-1155463 | A Bcl-xL inhibitor (Ki = is = 80 and 16 nM, respectively); inhibits the gr… | 1 mg | 27369-1 |
CAYMAN CHEMICAL COMPANY |
More Info |
| A-1155463 | A Bcl-xL inhibitor (Ki = is = 80 and 16 nM, respectively); inhibits the gr… | 10 mg | 27369-10 |
CAYMAN CHEMICAL COMPANY |
More Info |
| A-1155463 | A Bcl-xL inhibitor (Ki = is = 80 and 16 nM, respectively); inhibits the gr… | 25 mg | 27369-25 |
CAYMAN CHEMICAL COMPANY |
More Info |
| A-1155463 | A Bcl-xL inhibitor (Ki = is = 80 and 16 nM, respectively); inhibits the gr… | 5 mg | 27369-5 |
CAYMAN CHEMICAL COMPANY |
More Info |
| A-1210477 | A selective Mcl-1 inhibitor (Ki = 0.43 nM; IC50 = 26.2 nM); disrupts the i… | 1 mg | 21113-1 |
CAYMAN CHEMICAL COMPANY |
More Info |
| A-1210477 | A selective Mcl-1 inhibitor (Ki = 0.43 nM; IC50 = 26.2 nM); disrupts the i… | 10 mg | 21113-10 |
CAYMAN CHEMICAL COMPANY |
More Info |
| A-1210477 | A selective Mcl-1 inhibitor (Ki = 0.43 nM; IC50 = 26.2 nM); disrupts the i… | 25 mg | 21113-25 |
CAYMAN CHEMICAL COMPANY |
More Info |
| A-1210477 | A selective Mcl-1 inhibitor (Ki = 0.43 nM; IC50 = 26.2 nM); disrupts the i… | 5 mg | 21113-5 |
CAYMAN CHEMICAL COMPANY |
More Info |